[Polarisqb in PR Newswire] PolarisQB and Fujitsu announce pioneering drug discovery platform to speed up the process of bringing new drugs to market

DURHAM, N.C., March 19, 2020 /PRNewswire/ — Polaris^qb has partnered with Fujitsu to create a ground-breaking drug discovery platform combining quantum-inspired technology, machine learning, hybrid quantum mechanics and molecular mechanics simulations (QM/MM). This new platform enables significantly faster, more cost-effective discovery of novel lead molecules to develop new drugs. Polaris^qb and Fujitsu have begun a drug discovery project targeting Dengue Fever which has no approved treatments.

Read more here.